Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05927571 |
Title | A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Genentech, Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | ISR | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
The Alfred Hospital | RECRUITING | Prahan | Victoria | 3181 | Australia | Details |
Rambam Health Care Campus | RECRUITING | Haifa | 3109600 | Israel | Details | |
Sheba Medical Center - PPDS | RECRUITING | Ramat Gan | 5266202 | Israel | Details | |
Tel Aviv Sourasky Medical Center PPDS | RECRUITING | Tel Aviv-Yafo | 6423906 | Israel | Details | |
The Catholic University of Korea - Seoul St. Mary's Hospital (Kangnam St. Mary's Hospital) | RECRUITING | Seocho | 06591 | Korea, Republic of | Details | |
Seoul National University Hospital | RECRUITING | Seoul | 03080 | Korea, Republic of | Details | |
Samsung Medical Center - PPDS | RECRUITING | Seoul | 06351 | Korea, Republic of | Details |